FDA Prepares to Warn about Ultrasound Drugs
The FDA has issued an alert to warn physicians about the hazards of drugs called "micro-bubble contrast agents" used to enhance ultrasound images for the diagnosis of heart problems. The main drug at issue is Definity, made by Bristol-Myers Squibb Co., but a second drug known as Optison by General Electric Co. is also expected to receive warnings.
Continue reading "FDA Prepares to Warn about Ultrasound Drugs" »













